


Ask a doctor about a prescription for MIDAZOLAM SALA 15mg/3ml INJECTABLE SOLUTION
Package Leaflet: Information for the User
Midazolam Sala 15 mg/3 ml Solution for Injection and Infusion EFG
Read all of this leaflet carefully before you start using this medicine because it contains important information for you.
If you have any further questions, ask your doctor or pharmacist.
Contents of the pack
Midazolam Sala contains the active substance midazolam. This belongs to a group of medicines called “benzodiazepines”.
Midazolam Sala acts quickly and makes you feel sleepy or puts you to sleep. It will also calm and relax your muscles.
Midazolam Sala is used in adults:
Do not use Midazolam Sala if you are in one of these situations. If you are not sure, consult your doctor before using this medicine.
Warnings and precautions
Consult your doctor or nurse before using Midazolam Sala if:
If you are in any of these situations (or are unsure), consult your doctor or nurse before using Midazolam Sala.
If your child is going to start using this medicine:
Other medicines and Midazolam Sala
Tell your doctor or nurse if you are taking, have recently taken or might take any other medicines, including those obtained without a prescription and herbal products.
This is very important because Midazolam Sala can affect the action of other medicines. Similarly, other medicines can affect the action of Midazolam Sala.
In particular, tell your doctor if you are taking any of the following medicines:
If you are in any of these situations (or are unsure), consult your doctor before using Midazolam Sala.
Using Midazolam Sala with alcohol
Do not drink alcohol if you have been given Midazolam Sala. This is because it can make you very sleepy and cause breathing problems.
Midazolam Sala contains sodium
This medicine contains 6 mg of sodium (a major component of table salt/cooking salt) in each 3 ml ampoule. This is equivalent to 0.3% of the maximum recommended daily intake of sodium for an adult.
This medicine should only be administered by a doctor or nurse with experience in a properly equipped place for monitoring and treating side effects. This place may be a hospital, clinic or doctor's office. In particular, your breathing, heart and circulation will be monitored.
This medicine is not recommended for the treatment of newborns or babies under 6 months. However, if the doctor considers it necessary, it may be administered to newborns or babies under 6 months who are in intensive care.
How Midazolam Sala will be administered to you
You will be given this medicine in one of the following ways:
Dosage:
The recommended dose varies from patient to patient. Your doctor will decide the most suitable dose for you. It will depend on your age, weight and physical condition. It will also depend on why you need the medicine, your response to treatment and whether you are being given other medicines at the same time.
After administration of Midazolam Sala
After treatment, you should go home accompanied by an adult who can take care of you. This is because this medicine can make you feel sleepy or forgetful. It can also affect your concentration and coordination.
If you have been treated with this medicine for a long time, for example in intensive care, your body may start to get used to the medicine. This means that the effect may not be the same.
If you use more Midazolam Sala than you should
This medicine will be administered to you by a doctor or nurse. This means that it is unlikely that you will be given too much midazolam. However, if you are given too much by mistake, you may notice the following:
In case of overdose or accidental ingestion, consult your doctor or pharmacist immediately or call the Toxicology Information Service, telephone: 91 562 04 20, indicating the medicine and the amount taken
Long-term use of Midazolam Sala for sedation in intensive care
If you are given this medicine for a long period, the following may happen:
If you stop using Midazolam Sala
If you stop treatment suddenly after long-term use, you may experience withdrawal symptoms such as:
Your doctor will gradually reduce the dose towards the end of treatment with midazolam to avoid these effects.
If you have any other questions about the use of this medicine, ask your doctor or nurse.
Like all medicines, this medicine can cause side effects, although not everybody gets them.
The following side effects have been reported (frequency not known, cannot be estimated from the available data) when using Midazolam Sala.
Seek medical attention immediately or call for an ambulance if you experience any of the following side effects:
Stop using Midazolam Sala and consult your doctor immediately if you experience any of the following side effects. They can be life-threatening and may require urgent medical treatment:
You may also have difficulty breathing, make breathing sounds or have difficulty breathing, or pale skin, weak and rapid pulse, or feeling of loss of consciousness.
Potentially life-threatening side effects are more likely to occur in adults over 60 years old and in people who already have respiratory or heart problems. These side effects are also more likely if the injection is given too quickly or in high doses.
Other side effects:
Nervous system disorders and mental problems:
Heart and circulation disorders:
Reporting of side effects
If you experience any side effects, consult your doctor or pharmacist, even if they are not listed in this leaflet. You can also report them directly through the Spanish Medicines Monitoring System for Human Use: www.notificaRAM.es.
By reporting side effects, you can help provide more information on the safety of this medicine.
Your doctor or pharmacist is responsible for storing this medicine. They are also responsible for disposing of any unused midazolam correctly.
Keep this medicine out of the sight and reach of children.
Do not use this medicine after the expiry date which is stated on the label and carton after EXP. The expiry date is the last day of the month shown.
Do not freeze. A precipitate may form which dissolves when the contents are shaken at room temperature.
Composition of Midazolam Sala
Each 3 ml ampoule contains 15 mg of midazolam as hydrochloride.
Appearance of the Product and Container Content
Midazolam Sala is a clear, colorless or slightly yellowish solution.
Midazolam Sala 15 mg/3 ml is presented as an injectable solution in two different package sizes, 5 ampoules or 50 ampoules of 3 ml.
Only one package size may be marketed.
Marketing Authorization Holder and Manufacturer
Laboratorio Reig Jofre, S.A.
Gran Capitán, 10
08970 Sant Joan Despí (Barcelona)
Spain
Date of the Last Revision of this Leaflet:September 2023
Detailed information on this medicinal product is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) http://www.aemps.gob.es/.
--------------------------------------------------------------------------------------------------------------------
This information is intended only for healthcare professionals:
Midazolam Sala 15 mg/3 ml solution for injection and perfusion EFG
Preparation of the Solution for Perfusion
This medicinal product can be diluted with a 0.9% sodium chloride solution, 5% and 10% dextrose, 5% levulose, Ringer's solution, and Hartmann's solution with a mixing ratio of 15 mg of midazolam per 100-1000 ml of solution.
These solutions remain stable for 24 hours at room temperature or 3 days in the refrigerator at 2-8°C. Midazolam Sala should not be mixed with any solution other than those listed above. In particular, midazolam should not be diluted with 6% p/v dextran (with 0.9% sodium chloride) in glucose or mixed with an injection of an alkaline compound. Midazolam precipitates in hydrogen carbonate.
The injectable solution should be visually examined before administration. Only solutions without visible particles will be used.
More concentrated midazolam infusion solutions may cause midazolam precipitation, especially if the pH of the sample exceeds 4.5-5.
The dose of Midazolam Sala should be carefully calculated for each patient. Only a portion of the medicinal product may be required. Please pay attention to the accuracy of the required dose for each patient based on their body weight.
When the amount of medicinal product injected requires adjustment based on the patient's body weight, use the pre-filled graduated syringe to reach the required volume, discarding any excess before injection in the case of intramuscular or intravenous bolus injection.
Validity Period and Storage
Midazolam Sala is designed for single use. Eliminate any excess content. The use of this medicinal product for multiple administrations in the same or different patients is not recommended.
Before Opening
Midazolam Sala ampoules should not be frozen, as they may burst. Additionally, a precipitate may form that dissolves when the contents are shaken at room temperature.
After Dilution
Physical-chemical stability has been demonstrated in use conditions for the dilutions for 24 hours at room temperature (15°C-25°C) or for 3 days in the refrigerator at 2-8°C.
Disposal of Waste Products
Any unused medicinal product or waste material should be disposed of in accordance with local regulations.
The best alternatives with the same active ingredient and therapeutic effect.
Discuss dosage, side effects, interactions, contraindications, and prescription renewal for MIDAZOLAM SALA 15mg/3ml INJECTABLE SOLUTION – subject to medical assessment and local rules.